Search research articles
Contact Us
Filters
Showing results (41-50 of 84) with videos related to
Page
of 9
Sort By:
JAMA Cardiology
|
July 2, 2020
Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia
Maciej Banach, P Barton Duell, Antonio M Gotto, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
January 30, 2024
Chenodeoxycholic acid (CDCA) treatment during pregnancy in women with cerebrotendinous xanthomatosis (CTX): Lessons learned from 19 pregnancies
Tzipora C Falik Zaccai, Sharon Hassin-Baer, Nehama Cohen Kfir, et al.
Journal of Clinical Lipidology
|
September 15, 2024
Rapid achievement of low-density lipoprotein cholesterol goals within 1 month after acute coronary syndrome during combination therapy with rosuvastatin, ezetimibe and bempedoic acid: Initial experience from the LAI-REACT study
Kunal Mahajan, Raman Puri, P Barton Duell, et al.
Journal of Clinical Lipidology
|
April 13, 2021
Prevention of atherosclerotic cardiovascular disease in South Asians in the US: A clinical perspective from the National Lipid Association
Dinesh Kalra, Krishnaswami Vijayaraghavan, Geeta Sikand, et al.
Journal of the Endocrine Society
|
January 30, 2020
Molecular Characterization of Familial Hypercholesterolemia in a North American Cohort
Abhimanyu Garg, Sergio Fazio, P Barton Duell, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 14, 2021
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association
Gissette Reyes-Soffer, Henry N Ginsberg, Lars Berglund, et al.
JACC. Cardiovascular Imaging
|
June 18, 2018
Lipoprotein Apheresis Acutely Reverses Coronary Microvascular Dysfunction in Patients With Severe Hypercholesterolemia
Melinda D Wu, Federico Moccetti, Eran Brown, et al.
American Journal of Preventive Cardiology
|
April 17, 2025
Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive Cardiology
Seyedmohammad Saadatagah, Miriam Larouche, Mohammadreza Naderian, et al.
JAMA
|
November 13, 2019
Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial
Anne C Goldberg, Lawrence A Leiter, Erik S G Stroes, et al.
Journal of Clinical Lipidology
|
May 13, 2025
Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive Cardiology
Seyedmohammad Saadatagah, Miriam Larouche, Mohammadreza Naderian, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 84) with videos related to
Sort By:
Page
of 9
JAMA Cardiology
|
July 2, 2020
Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia
Maciej Banach, P Barton Duell, Antonio M Gotto, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
January 30, 2024
Chenodeoxycholic acid (CDCA) treatment during pregnancy in women with cerebrotendinous xanthomatosis (CTX): Lessons learned from 19 pregnancies
Tzipora C Falik Zaccai, Sharon Hassin-Baer, Nehama Cohen Kfir, et al.
Journal of Clinical Lipidology
|
September 15, 2024
Rapid achievement of low-density lipoprotein cholesterol goals within 1 month after acute coronary syndrome during combination therapy with rosuvastatin, ezetimibe and bempedoic acid: Initial experience from the LAI-REACT study
Kunal Mahajan, Raman Puri, P Barton Duell, et al.
Journal of Clinical Lipidology
|
April 13, 2021
Prevention of atherosclerotic cardiovascular disease in South Asians in the US: A clinical perspective from the National Lipid Association
Dinesh Kalra, Krishnaswami Vijayaraghavan, Geeta Sikand, et al.
Journal of the Endocrine Society
|
January 30, 2020
Molecular Characterization of Familial Hypercholesterolemia in a North American Cohort
Abhimanyu Garg, Sergio Fazio, P Barton Duell, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 14, 2021
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association
Gissette Reyes-Soffer, Henry N Ginsberg, Lars Berglund, et al.
JACC. Cardiovascular Imaging
|
June 18, 2018
Lipoprotein Apheresis Acutely Reverses Coronary Microvascular Dysfunction in Patients With Severe Hypercholesterolemia
Melinda D Wu, Federico Moccetti, Eran Brown, et al.
American Journal of Preventive Cardiology
|
April 17, 2025
Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive Cardiology
Seyedmohammad Saadatagah, Miriam Larouche, Mohammadreza Naderian, et al.
JAMA
|
November 13, 2019
Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial
Anne C Goldberg, Lawrence A Leiter, Erik S G Stroes, et al.
Journal of Clinical Lipidology
|
May 13, 2025
Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive Cardiology
Seyedmohammad Saadatagah, Miriam Larouche, Mohammadreza Naderian, et al.
Page
of 9